James Allison.
Co-founder of immune checkpoint therapy
He pioneered cancer immunotherapy using T-cells.
His work revolutionized cancer treatment worldwide.
In 1948, he was born in the USA.
In 1973, he earned his PhD in Biochemistry from the University of Texas.
In 1994, he discovered CTLA-4 blockade for cancer therapy.
1. Immune checkpoint therapy, a method that unleashes the immune system to attack tumors.
2. It improved survival rates in multiple cancers.
3. It led to a new class of cancer drugs.
In 2018, he received the Nobel Prize in Physiology or Medicine.
His research reshaped cancer treatment globally.
He currently leads research at the MD Anderson Cancer Center.
Want to know more stories?
Visit James Allison.